Lennart Olsson
University of Copenhagen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lennart Olsson.
Cancer | 1984
Lennart Olsson; Hans Rahbek Sōensen; Olav Behnke
Cloned cell lines and a number of subclones from these lines were established in vitro from biopsies of small cell lung carcinomas and squamous cell lung carcinomas. The cloned cultures, including the cloned subclones, were analyzed in respect to morphology, karyotype, growth rates, clonogenicity in semisolid agar medium, and tumorigenicity in nude mice. A remarkable biologic diversity was found in respect to most of these biologic features. In addition, four murine monoclonal antibodies with high specificity for lung tumor cells were generated. Their reactivity pattern to clonogenic cells was for some clones different as compared to the nonclonogenic cells. Subclones of tumor cells not binding the antibody were identified for each monoclonal antibody. It is concluded that intratumoral phenotypic diversity may have a severe negative impact on the use of monoclonal antibodies in cancer diagnosis/therapy. The work also indicates that a mixture of antibodies may be more useful in tumor diagnosis than individual antibodies and perhaps even therapy, particularly if they bind to the clonogenic part of a cell population.
Cell Proliferation | 1975
Lennart Olsson; Mogens H. Claesson
Cell proliferation in the murine thymus was studied in vivo under normal conditions and from 0 to 24 hr after a single injection of a water‐soluble extract from mouse thymus, mouse spleen, and mouse skin. The thymus extract reduced during the first 24 hr the mitotic activity 40%; the spleen extract had a weaker inhibitory effect. The skin extract had no such effect. The thymus extract and spleen extract inhibited the flux of cells into the S phase 0–8 hr after the injection of the extract. Initial labelling index was also reduced in this period. Eight hours after injection of the thymus or spleen extracts the inhibited cells initiated DNA synthesis. The rate of progression of blast cells through the cell cycle was normal 24 hr after the injection of the extracts.
International Journal of Cancer | 1985
Lennart Olsson; Olav Behnke; Hans Rahbek Sørensen
Journal of the National Cancer Institute | 1984
Lennart Olsson; Olav Behnke; Nancy Pleibel; Francesco D'Amore; Ole Werdelin; Kirk E. Fry; Henry S. Kaplan
Acta Pathologica Microbiologica Scandinavica Section A Pathology | 2009
Mogens H. Claesson; Ole Steen Jørgensen; Lennart Olsson
Journal of Structural Biology | 1996
Larry H. Weaver; Jan Stagsted; Olav Behnke; Brian W. Matthews; Lennart Olsson
Scandinavian Journal of Haematology | 2009
N. Tinggaard Pedersen; Mads Hansen; Lennart Olsson
Hematological Oncology | 1988
Lennart Olsson; Olav Behnke
Scandinavian Journal of Haematology | 2009
Mogens H. Claesson; Lennart Olsson
Scandinavian Journal of Haematology | 2009
N. Tinggaard Pedersen; Mads Hansen; Lennart Olsson